FDA OKs Lupin’s generic cough syrup

Mumbai, India-based Lupin earned Food and Drug Administration approval for its generic cough syrup, according to Drug Store News.

Advertisement

Here are three things to know.

1. The syrup is a combination of hydrocodone bitartrate — a narcotic that suppresses the cough reflex in the brain — and homatrophine methylbromide, which dries up mucus or secretions.

2. The drug is intended to relieve cough symptoms in adults and children six years and older.

3. Lupin’s cough syrup is a generic version of Endo Pharmaceuticals’ Hycodan Oral solution.

More articles on supply chain:

4 thoughts from Trump’s CMS pick on reducing federal drug spending
Prime Therapeutics reports 2.5% increase in drug spending for 2016
FDA approves Valeant’s psoriasis drug

At the Becker's 11th Annual IT + Revenue Cycle Conference: The Future of AI & Digital Health, taking place September 14–17 in Chicago, healthcare executives and digital leaders from across the country will come together to explore how AI, interoperability, cybersecurity, and revenue cycle innovation are transforming care delivery, strengthening financial performance, and driving the next era of digital health. Apply for complimentary registration now.

Register to Attend Webinar

Beyond the bottleneck: How health systems are improving access, flow and care continuity

Thursday, July 30
1:00 PM - 2:00 PM CDT

Presenters: Imamu Tomlinson, MD, MBA, VituityWilliam Morice II, MD, PhD, Mayo Clinic LaboratoriesJordan Dale, MD, Houston MethodistAsh Tengshe, City of HopeChris Klay, MHA, MA, PT, FACHE, Hospital Sisters Health System

Advertisement

Next Up in Supply Chain

Advertisement

Comments are closed.